It is a wonderful honor to serve as Guest Editor of this venous disease–focused issue of Endovascular Today and collaborate with its outstanding authors and editorial staff. As we launch into 2025, it ...
CereVasc, Inc. announced the randomization of the first patient in the multicenter STRIDE clinical trial of the company’ ...
Prof. Ducasse reflects on AI for aortic aneurysms, the state of carotid intervention in France, current and upcoming research ...
Dania Daye, MD, PhD Associate Professor of Radiology, Harvard Medical School IR Division Quality Director Co-Director of IR ...
Embolization has made remarkable advances in recent years, becoming a widely adopted treatment option. The FDA approved the ...
Dr. Jafar Golzarian discusses his move from academic practice to an OBL, case selection and procedure planning, ...
Patient selection, imaging techniques, procedural insights, strategies for optimizing patient outcomes, and more.
In a secondary analysis of the BEST-CLI trial, McGinigle et al found lower rates of major adverse limb events (MALE) and ...
Cerenovus PulseRider Aneurysm Neck Bridging Device T shape, Y shape 2.7–3.5, 3.4–4.5 8.6, 10.6 ...
Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm-diameter balloon; guidewire-free) Aortic Temporary occlusion of large blood vessels and/or ...
Serenity Medical announced the publication of 1-year results of the RIVER study by Athos Patsalides, MD, et al in Journal of N ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback